Metraipolis › archive › dc_4a8ffb26ef68
Sinonasal microbiome remains stable during dupilumab therapy in chronic rhinosinusitis: a pilot study — Europe PMC PMID:42289567
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42289567
- DOI
- 10.1007/s00405-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T11:18:32.728Z
- SHA-256 of the archived text
1dd8898b9800eb6a19ae736f5e7423af25a38ce743d4d94eb1b9acdc4fb2506b- Stable URL of this page
https://metraipolis.com/documento/dc_4a8ffb26ef68
How to cite
Sinonasal microbiome remains stable during dupilumab therapy in chronic rhinosinusitis: a pilot study — Europe PMC PMID:42289567 — Europe PMC (en), https://europepmc.org/article/MED/42289567 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a8ffb26ef68 (Metraipolis archive dc_4a8ffb26ef68, sha256 1dd8898b9800eb6a19ae736f5e7423af25a38ce743d4d94eb1b9acdc4fb2506b)
BibTeX
@misc{dc4a8ffb26ef68,
title = {Sinonasal microbiome remains stable during dupilumab therapy in chronic rhinosinusitis: a pilot study — Europe PMC PMID:42289567},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42289567},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a8ffb26ef68; sha256 1dd8898b9800eb6a19ae736f5e7423af25a38ce743d4d94eb1b9acdc4fb2506b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42289567. Agents can read the archived copy with the MCP tool read_document.